Molecular Therapeutics BIPH 3222D

Course description:

This course involves a wide range of new disease therapies such as simple protein replacement therapy, gene augmentation therapy, antisense therapy, Triple helix (triplex) technology, Ribozymes , stem cells therapy and new cancer therapies, some are applicable to microbial, inherited and acquired disease while other therapies to be described are still at the clinical trials stage and are not yet available for patient.

Course Aims:

The course aims at introducing students to a new and developing science which involves recombinant DNA technology, protein production and purification, molecular biology and biotechnology.

Course outcomes:

Upon successful completion of this course students will able to:
  • Demonstrate an in-depth knowledge of recent developments in molecular therapeutics research specifically in the areas of G protein-coupled receptors, transcription factors and molecular drug development.
  • Critically discuss the contribution that recent advances in molecular therapeutics have made (or may make in the future) to human health specifically in the areas of G-protein-coupled receptors, transcription factors and molecular drug development. 
  • Demonstrate an in-depth knowledge of recent developments in molecular therapeutics research specifically in the treatment of cancer, immune diseases and pain.
  • Critically discuss the contribution that recent advances in molecular therapeutics have made (or may make in the future) to human health specifically in the treatment of cancer, immune diseases and pain.